TYROBP and TREM2 form a receptor complex on macrophages which has been extensively studied in the context of neurodegenerative diseases, where the complex mediates signaling and cell activation following binding to its ligands including APOE or β-amyloid (a cleavage product of the amyloid-beta precursor protein APP)93–95. Here, APP is linked to neurodegenerative disease.